AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6426830 — Biomarker: GNRH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GNRH1; GNRH; GRH; LHRH
Study 23675990 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 20442989 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 16021194 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8672323 — Biomarker: TAT mRNA
Type: Predictive Biomarker (PRD)
Genes: TAT
Study 31033154 — Biomarker: MVD mRNA
Type: Predictive Biomarker (PRD)
Genes: MVD; MPD
Study 24004517 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29261442 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 27585671 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 18716362 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18716362 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 18716362 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 18716362 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 15729174 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 12775230 — Biomarker: Bcl-2 to Bax
Type: Pharmacodynamic Biomarker (PDY)
Study 23180751 — Biomarker: C2 mRNA
Type: Predictive Biomarker (PRD)
Genes: C2
Study 23180751 — Biomarker: Complement C3
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: C3; CPAMD1
Study 23180751 — Biomarker: Complement C5
Type: Pharmacodynamic Biomarker (PDY)
Genes: C5; CPAMD4
Study 23180751 — Biomarker: C6 mRNA
Type: Predictive Biomarker (PRD)
Genes: C6
Study 15505150 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 9684799 — Biomarker: TFPI mRNA
Type: Predictive Biomarker (PRD)
Genes: TFPI; LACI; TFPI1
Study 21128827 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 21128827 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 24997005 — Biomarker: von Willebrand factor
Type: Safety Biomarker (SAF)
Genes: VWF; F8VWF
Study 9535150 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2173168 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 22151296 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 17374034 — Biomarker: OPRK1 mRNA
Type: Predictive Biomarker (PRD)
Genes: OPRK1; OPRK
Study 17374034 — Biomarker: OPRD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: OPRD1; OPRD
Study 22419369 — Biomarker: SPARC mRNA
Type: Predictive Biomarker (PRD)
Genes: SPARC; ON
Study 22419369 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 28623944 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 16940406 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16940406 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 12930031 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16641119 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 16641119 — Biomarker: Immunoglobulin E
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 16369129 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 16369129 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 7920884 — Biomarker: TPO mRNA
Type: Predictive Biomarker (PRD)
Genes: TPO
Study 29538636 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 29876530 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 27178989 — Biomarker: Myeloperoxidase
Type: Safety Biomarker (SAF)
Genes: MPO
Study 20012601 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 17413685 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21543375 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 21543375 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 10818057 — Biomarker: Serum potassium
Type: Surrogate Endpoint (SUR)
Study 2439827 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28964662 — Biomarker: CD40 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD40; TNFRSF5
Study 23195006 — Biomarker: SRL mRNA
Type: Predictive Biomarker (PRD)
Genes: SRL
Study 9168506 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 26821621 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 24582900 — Biomarker: MCIDAS mRNA
Type: Predictive Biomarker (PRD)
Genes: MCIDAS; IDAS; MCI; MCIN
Study 16402634 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 16402634 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 16402634 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 30727980 — Biomarker: Duration of severe neutropenia
Type: Surrogate Endpoint (SUR)
Study 26475420 — Biomarker: SPN mRNA
Type: Predictive Biomarker (PRD)
Genes: SPN; CD43
Study 1108582 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11783328 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 25431431 — Biomarker: CIT mRNA
Type: Predictive Biomarker (PRD)
Genes: CIT; CRIK; KIAA0949; STK21
Study 15040538 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 15040538 — Biomarker: CCR7 mRNA
Type: Predictive Biomarker (PRD)
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 3630804 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31285069 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15041578 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8061854 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29961572 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 29961572 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 29961572 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 11677359 — Biomarker: ANG mRNA
Type: Predictive Biomarker (PRD)
Genes: ANG; RNASE5
Study 11677359 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 11677359 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29221717 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 29221717 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24618153 — Biomarker: Cellular tumor antigen p53
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: TP53; P53
Study 24618153 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24618153 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study 1482267 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15795365 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12486649 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2350052 — Biomarker: Blood coagulation
Type: Pharmacodynamic Biomarker (PDY)
Study 9506008 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 23939953 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 26717219 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21654521 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 15811062 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study 12459402 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 21793388 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 19010579 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study 19010579 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9833910 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 799564 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30967530 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 30967530 — Biomarker: BDNF
Type: Safety Biomarker (SAF)
Study 28287798 — Biomarker: CAST mRNA
Type: Predictive Biomarker (PRD)
Genes: CAST
Study 25953971 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17923131 — Biomarker: AMH mRNA
Type: Predictive Biomarker (PRD)
Genes: AMH; MIF
Study 16197663 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 24626998 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 22320241 — Biomarker: SRL mRNA
Type: Predictive Biomarker (PRD)
Genes: SRL
Study 15729065 — Biomarker: ACD mRNA
Type: Predictive Biomarker (PRD)
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 2668464 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30480353 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 30480353 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 30480353 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 27987228 — Biomarker: NE
Type: Predictive Biomarker (PRD)
Study 25204316 — Biomarker: CD46 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD46; MCP; MIC10
Study 25204316 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 25204316 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25204316 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 25953327 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 19829124 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 30112581 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 19178509 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 31513531 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15305234 — Biomarker: HLA-DRB1
Type: Safety Biomarker (SAF)
Genes: HLA-DR1B
Study 15305234 — Biomarker: HLA-DQB1
Type: Safety Biomarker (SAF)
Genes: IDDM1; CELIAC1
Study 15448423 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 20470379 — Biomarker: GNRH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GNRH1; GNRH; GRH; LHRH
Study 18383390 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 16100773 — Biomarker: TP53
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: p53; LFS1
Study 16100773 — Biomarker: Ki-67
Type: Predictive Biomarker (PRD)
Genes: MKI67; MIB-1; PPP1R105
Study 12426515 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 2236455 — Biomarker: SDS mRNA
Type: Predictive Biomarker (PRD)
Genes: SDS; SDH
Study 26376822 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 18029489 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 16148184 — Biomarker: IGFALS mRNA
Type: Predictive Biomarker (PRD)
Genes: IGFALS; ALS
Study 10376852 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 10376852 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1984505 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 21149919 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 10200809 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8706198 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2357134 — Biomarker: LPL mRNA
Type: Predictive Biomarker (PRD)
Genes: LPL; LIPD
Study 24372992 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 19605528 — Biomarker: Serum LDL cholesterol
Type: Surrogate Endpoint (SUR)
Study 7599569 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 7599569 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 28101704 — Biomarker: Platelet glycoprotein 4
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: CD36; GP3B; GP4
Study 21559987 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 11699052 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 2467136 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27979834 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study 9579235 — Biomarker: CRH mRNA
Type: Predictive Biomarker (PRD)
Genes: CRH
Study 29927785 — Biomarker: DMD
Type: Predictive Biomarker (PRD)
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 29927785 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 27239927 — Biomarker: Cytochrome P450 2C19
Type: Safety Biomarker (SAF)
Genes: CYP2C19
Study 17709365 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 12006508 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 2765377 — Biomarker: NAT8 mRNA
Type: Predictive Biomarker (PRD)
Genes: NAT8; CML1; GLA; TSC501
Study 18316547 — Biomarker: Epidermal growth factor
Type: Monitoring Biomarker (MOI)
Genes: EGF
Study 22236488 — Biomarker: ARCN1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ARCN1; COPD
Study 20132138 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 10567754 — Biomarker: Complement C7
Type: Monitoring Biomarker (MOI)
Genes: C7
Study 10567754 — Biomarker: C6 mRNA
Type: Predictive Biomarker (PRD)
Genes: C6
Study 25490913 — Biomarker: CS mRNA
Type: Predictive Biomarker (PRD)
Genes: CS
Study 23890351 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23890351 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 23890351 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 23890351 — Biomarker: Matrix metalloproteinase 9
Type: Pharmacodynamic Biomarker (PDY)
Genes: MMP9; CLG4B
Study 14990595 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study 11374092 — Biomarker: EEF1A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: EEF1A2; EEF1AL; STN
Study 9404766 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25618800 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25618800 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 16967629 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 16967629 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 9011450 — Biomarker: CCK mRNA
Type: Predictive Biomarker (PRD)
Genes: CCK
Study 9011450 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 29321218 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11899903 — Biomarker: MVP mRNA
Type: Predictive Biomarker (PRD)
Genes: MVP; LRP
Study 11899903 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 26301771 — Biomarker: SDS mRNA
Type: Predictive Biomarker (PRD)
Genes: SDS; SDH
Study 4042527 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 20034816 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 10103305 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 2260333 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18423807 — Biomarker: Beta-2-microglobulin
Type: Safety Biomarker (SAF)
Genes: B2M; CDABP0092; HDCMA22P
Study 18423807 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16503669 — Biomarker: MIF mRNA
Type: Predictive Biomarker (PRD)
Genes: MIF; GLIF; MMIF
Study 10679908 — Biomarker: von Willebrand factor
Type: Safety Biomarker (SAF)
Genes: VWF; F8VWF
Study 1606113 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18826853 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 15796145 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 12783045 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 10542989 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 10542989 — Biomarker: Heat shock 70 kDa
Type: Safety Biomarker (SAF)
Study 10542989 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 19244174 — Biomarker: GNRH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GNRH1; GNRH; GRH; LHRH
Study 8045953 — Biomarker: CRH mRNA
Type: Predictive Biomarker (PRD)
Genes: CRH
Study 23894039 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 16825698 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9744143 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30825342 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20924595 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19781408 — Biomarker: Cholesteryl ester transfer protein
Type: Pharmacodynamic Biomarker (PDY)
Genes: CETP
Study 19781408 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19781408 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19781408 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31306056 — Biomarker: PC mRNA
Type: Predictive Biomarker (PRD)
Genes: PC
Study 28916311 — Biomarker: Cellular tumor antigen p53
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: TP53; P53
Study 12859326 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 6373331 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30052208 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 17666915 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 8089770 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 31838002 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 16946209 — Biomarker: BRCA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA1; RNF53
Study 16946209 — Biomarker: BRCA2 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA2; FACD; FANCD1
Study 14696021 — Biomarker: SST mRNA
Type: Predictive Biomarker (PRD)
Genes: SST
Study 14696021 — Biomarker: DST mRNA
Type: Predictive Biomarker (PRD)
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 29295516 — Biomarker: CPT1B mRNA
Type: Predictive Biomarker (PRD)
Genes: CPT1B; KIAA1670
Study 29295516 — Biomarker: CHKB mRNA
Type: Predictive Biomarker (PRD)
Genes: CHKB; CHETK; CHKL
Study 29295516 — Biomarker: GNAS mRNA
Type: Predictive Biomarker (PRD)
Genes: GNAS; GNAS1
Study 11436117 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 11436117 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 2527819 — Biomarker: Cyclic guanosine monophosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 2527819 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 2527819 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28287415 — Biomarker: Interleukin 10
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL10
Study 23648392 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15587751 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 15587751 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 15587751 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 15587751 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 30150192 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22161771 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 31477161 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study 16982294 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 3908417 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29250742 — Biomarker: HSPB1 mRNA
Type: Predictive Biomarker (PRD)
Genes: HSPB1; HSP27; HSP28
Study 29250742 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 26321218 — Biomarker: SERPINA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 20357761 — Biomarker: Valproic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 11811507 — Biomarker: Lymphocyte activation antigen CD30
Type: Predictive Biomarker (PRD)
Genes: TNFRSF8; CD30; D1S166E
Study 2525998 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8803642 — Biomarker: TAT mRNA
Type: Predictive Biomarker (PRD)
Genes: TAT
Study 20625187 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 20625187 — Biomarker: RPE mRNA
Type: Predictive Biomarker (PRD)
Genes: RPE; HUSSY-17
Study 27473676 — Biomarker: EBF1 mRNA
Type: Predictive Biomarker (PRD)
Genes: EBF1; COE1; EBF
Study 14520027 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 1649265 — Biomarker: CAV1 mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAV1; CAV
Study 19636011 — Biomarker: Trefoil factor 3
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: TFF3; ITF; TFI
Study 16179822 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4